Considerations in assessing the clinical course and severity of rotavirus gastroenteritis

Clinical Pediatrics

Volumn 45, Issue 3, 2006, Pages 203-212

  D'Agostino, James ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIBIOTIC AGENT; ANTIDIARRHEAL AGENT; ANTIVIRUS AGENT; ATROPINE; CYSTEINE PROTEINASE INHIBITOR; GLUCOSE; GROWTH FACTOR; IMMUNOGLOBULIN; KAOLIN PECTIN; LOPERAMIDE; ORAL REHYDRATION SOLUTION; POTASSIUM CHLORIDE; PROBIOTIC AGENT; RINGER LACTATE SOLUTION; SODIUM CHLORIDE;

ANAMNESIS; ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL TRIAL; DEHYDRATION; DIARRHEA; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DRUG FATALITY; GASTROENTERITIS; HOSPITAL ADMISSION; HUMAN; ILEUS; LABORATORY TEST; LETHARGY; META ANALYSIS; NAUSEA; ORAL REHYDRATION THERAPY; PHYSICAL EXAMINATION; ROTAVIRUS; SCORING SYSTEM; SEIZURE; SYSTEMATIC REVIEW; VIRUS INFECTION;

ADULT; CHILD; FLUID THERAPY; GASTROENTERITIS; HUMANS; INFANT; MALE; ROTAVIRUS INFECTIONS; SEVERITY OF ILLNESS INDEX;

EID: 33646870336     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/000992280604500301     Document Type: Article

References (51)

1. Spitzer MD. Viral causes of diarrhea. Pediatr Rev. 2002;23:257-258.
2. Glass RI, Bresee J, Jiang B, et al. Gastroenteritis viruses: an overview. Novartis Found Symp. 2001;238:5-19; discussion 19-25.
3. Parashar UD, Hummelman EG, Bresee JS, et al. Global illness and death caused by rotavirus disease in children. Emerg Infect Dis. 2003;9:565-572.
4. Cornell SL. Confronting the consequences of rotavirus: diarrhea and dehydration. Adv Nurse Pract. 1997;5:41-44.
5. Gastroenteritis. In: Beers MH, Berkow R, eds. Merck Manual. 17th ed. Whitehouse Station, NJ: Merck & Co., Inc. 1999-2004; available online: http://www.merck.com/mrkshared/mmanual/section3/chapter28/28a.jsp. Accessed: November 17, 2004.
6. Staat MA, Azimi PH, Berke T, et al. Clinical presentation of rotavirus infection among hospitalized children. Pediatr Infect Dis J. 2002;21:221-227.
7. Ruuska T, Vesikari T. Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhea1 episodes. Stand J Infect Dis. 1990;22:259-267.
8. Alam NH, Ashraf H. Treatment of infectious diarrhea in children. Paediatr Drugs. 2003;5:151-165.
9. Farthing MJ. Treatment of gastrointestinal viruses. Novartis Found Symp. 2001;238:289-300; discussion 300-305.
10. Sandhu BK, for the European Society of Pediatric Gastroenterology, Hepatology, and Nutrition Working Group on Acute Diarrhea. Practical guidelines for the management of gastroenteritis in children. J Pediatr Gastroenterol Nutr. 2001;33:S36-S39.
11. King CK, Glass R, Bresee JS. Managing acute gastroenteritis among children. Morb Mortal Wkly Rep. 2003;52(RR16):1-16.
12. Hjelt K, Grauballe PC, Andersen I, et al. Antibody response in serum and intestine in children up to six months after a naturally acquired rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr. 1986;5:74-80.
13. Flores J, Perez-Schael I, Gonzalez M, et al. Protection against severe rotavirus diarrhea by rhesus rotavirus vaccine in Venezuelan infants. Lancet. 1987;8538:882-884.
14. Vesikari T, Isolauri E, Baer M. A comparative trial of rapid oral and intravenous rehydration in acute diarrhea. Acta Paediatr Scand. 1987;76:300-305.
15. Clark HF, Berstein DI, Dennehy PH, et al. Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants. J Pediatr. 2004;144:184-190.
16. Clark HF, Borian FE, Bell LM, et al. Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype I rotavirus season. J Infect Dis. 1988;158:570-587.
17. Duffy LC, Byers TE, Riepenhoff-Talty M, et al. The effects of infant feeding on rotavirus-induced gastroenteritis: a prospective study. Am J Public Health. 1986;76:259-263.
18. The Treatment of Diarrhoea: A Manual for Physicians and Other Senior Health Workers. Geneva: World Health Organization. 2003. Report No. WHO/CDD/SER/80.2 Rev. 4.
19. Guarino A, Albano F. Guidelines for the approach to outpatient children with acute diarrhea. Acta Pediatr. 2001;90:1087-1095.
20. Victoria CG, Bryce J, Fontaine O, et al. Reducing deaths from diarrhea through oral rehydration therapy. Bull World Health Organ. 2000;78:1246-1255.
21. Bellemare S, Hartling L, Wiebe N, et al. Oral rehydration versus intravenous therapy for treating dehydration due to gastroenteritis in children: a meta-analysis of randomised controlled trials. BMC Med. 2004;2:11; available online: http://www.biomedcentral.com/1741-7015/2/11. Accessed February 28, 2005.
22. Fonseca BK, Holdgate A, Craig JC. Enteral vs intravenous rehydration therapy for children with gastroenteritis: a meta-analysis of randomized controlled trials. Arch Pediatr Adolesc Med. 2004;158:483-490.
23. Molla A, Molla AM, Sarker SA, et al. Whole-gut transit time and its relationship to absorption of macronutrients during diarrhea and after recovery. Scand J Gastroenterol. 1983;18:537-543.
24. Brown KH, Gastanaduz AS, Saavedra JM. Effect of continued oral feeding on clinical and nutritional outcomes of acute diarrhea in children. J Pediatr. 1988;112:191-200.
25. Isolauri E, Juntenen M, Wiren S, et al. Intestinal permeability changes in acute gastroenteritis: effects of clinical factors and nutritional management. J Pediatr Gastroenterol Nutr. 1989;8:466-473.
26. Provisional Committee on Quality Improvement, Subcommittee on Acute Gastroenteritis. Practice parameter: the management of acute gastroenteritis in young children. Pediatrics. 1996;97:424-436.
27. Khin MU, Nyunt-Nyunt-Wai, Myo-Khin, et al. Effect on clinical outcome of breast feeding during acute diarrhoea. Br Med J (Clin Res Ed). 1985;290:587-589.
28. Fontaine O. Effect of zinc supplementation on clinical course of acute diarrhea. J Health Popul Nutr. 2001;19:339-346.
29. Guarino A, Canani RB, Spagnuolo MI, et al. Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhea. J Pediatr Gastroenterol Nutr. 1997;25:516-519.
30. Isolauri E, Juntunen M, Rautanen T, et al. A human lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics. 1991;88:90-97.
31. Isolauri E, Kaila M, Mykkanen H, et al. Oral bacteriotherapy for viral gastroenteritis. Dig Dis Sci. 1994;39:2595-2600.
32. Kaila M, Isolauri E, Saxelin M, et al. Viable versus inactivated lactobacillus strain GG in acute rotavirus diarrhea. Arch Dis Child. 1995;72:51-53.
33. Majamaa H, Isolauri E, Saxelin M, Vesikari T. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr. 1995;2:333-338.
34. Shornikova AV, Casas IA, Mykkanen H, et al. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr Infect Dis J. 1997;16:1103-1107.
35. Shornikova AV, Isolauri E, Burkanova L, et al. A trial in the Karelian Republic of oral rehydration and Lactobacillus GG for the treatment of acute diarrhea. Acta Paediatr. 1997;86:460-465.
36. Shornikova AV, Casas IA, Isolauri E, et al. Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children. J Pediatr Gastroenterol Nutr. 1997;24:399-404.
37. Ebina T, Tsukada K. Protease inhibitors prevent the development of human rotavirus-induced diarrhea in suckling mice. Microbiol Immunol. 1991;35:583-588.
38. Haffejee IE. Effect of oral folate on duration of acute diarrhoea. Lancet. 1988;II:334-335.
39. Haffejee IE. Folate for diarrhea. Dialogue Diarrhoea. 1990;43:2.
40. Ashraf H, Rahman MM, Fuchs GJ, et al. Folic acid in the treatment of acute watery diarrhea in children: a double-blind, randomized, controlled trial. Acta Paediatr. 1998;87:1113-1115.
41. Zijlstra RT, Odle J, Hall WF, et al. Effect of orally administered epidermal growth factor on intestinal recovery of neonatal pigs infected with rotavirus. J Pediatr Gastroenterol Nutr. 1994;19:382-390.
42. Rhoads JM, Ulshen MH, Keku EO, et al. Oral transforming growth factor-alpha enhances jejunal mucosal recovery and electrical resistance in piglet rotavirus enteritis. Pediatr Res. 1995;38:173-181.
43. Guarino A, Canani RB, Russo S, et al. Oral immunoglobulins for treatment of acute rotaviral gastroenteritis. Pediatrics. 1994;93:12-16.
44. Hilpert H, Brussow H, Mietens C, et al. Use of bovine milk concentrate containing antibody to rotavirus to treat rotavirus gastroenteritis in infants. J Infect Dis. 1987;156:158-166.
45. Mitra AK, Mahalanabis D, Ashraf H, et al. Hyperimmune cow colostrums reduces diarrhea due to rotavirus: a double-blind, controlled clinical trial. Acta Paediatr. 1995;84:996-1001.
46. Sarker SA, Casswall TH, Mahalanabis D, et al. Successful treatment of rotavirus diarrhea in children with immunoglobulin from immunized bovine colostrums. Pediatr Infect Dis J. 1998;17:1149-1154.
47. Hodgins DC, Kang S-Y, deArriba L, et al. Effects of maternal antibodies on protection and the development of antibody responses to human rotavirus in gnotobiotic pigs. J Virol. 1999;73:186-197.
48. Parreno V, deArriba L, Kang S, et al. Serum and intestinal isotype antibody responses to Wa human rotavirus induced diarrhea in gnotobiotic pigs are modulated by maternal antibodies. J Gen Virol. 1999;80:1417-1428.
49. Schaller JP, Saif LJ, Cordle CT, et al. Prevention of human rotavirus induced diarrhea in gnotobiotic piglets using bovine antibody. J Infect Dis. 1992;165:623-630.
50. Leece JG, Cummins JM, Richards AB. Treatment of rotavirus infection in neonate and weanling pigs using natural human interferon alpha. Mol Biother. 1990;2:212-216.
51. Alam NH, Meier R, Scheinder H, et al. Partially hydrolyzed guar gum supplemented oral rehydration solution in the treatment of acute diarrhea in children. J Pediatr Gastroenterol Nutr. 2000;31:503-557.